Literature DB >> 17440149

Use of epoetin in chronic renal failure.

Daniel W Coyne.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17440149     DOI: 10.1001/jama.297.15.1713

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  Mortality associated with dose response of erythropoiesis-stimulating agents in hemodialysis versus peritoneal dialysis patients.

Authors:  Uyen Duong; Kamyar Kalantar-Zadeh; Miklos Z Molnar; Joshua J Zaritsky; Isaac Teitelbaum; Csaba P Kovesdy; Rajnish Mehrotra
Journal:  Am J Nephrol       Date:  2012-01-26       Impact factor: 3.754

Review 2.  Too much of a good thing.

Authors:  Alison Tonks
Journal:  BMJ       Date:  2007-05-12

Review 3.  The landscape of clinical trials in nephrology: a systematic review of Clinicaltrials.gov.

Authors:  Jula K Inrig; Robert M Califf; Asba Tasneem; Radha K Vegunta; Christopher Molina; John W Stanifer; Karen Chiswell; Uptal D Patel
Journal:  Am J Kidney Dis       Date:  2013-12-06       Impact factor: 8.860

4.  Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients.

Authors:  Kamyar Kalantar-Zadeh; Grace H Lee; Jessica E Miller; Elani Streja; Jennie Jing; John A Robertson; Csaba P Kovesdy
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

5.  Impact of the End Stage Renal Disease Prospective Payment System on the Use of Peritoneal Dialysis.

Authors:  Qian Zhang; Mae Thamer; Onkar Kshirsagar; Yi Zhang
Journal:  Kidney Int Rep       Date:  2016-12-20

6.  The future of intravenous iron in nephrology.

Authors:  Daniel W Coyne
Journal:  NDT Plus       Date:  2011-06

Review 7.  Uremic Toxins Affect Erythropoiesis during the Course of Chronic Kidney Disease: A Review.

Authors:  Eya Hamza; Laurent Metzinger; Valérie Metzinger-Le Meuth
Journal:  Cells       Date:  2020-09-06       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.